News

CMN Weekly (11 March 2022) - Your Weekly CRISPR Medicine News

Some of the best links we picked up around the internet

By: Gorm Palmgren - Mar. 11, 2022

Top picks

Research

Industry

Detection

Reviews

  • A review by Spanish researchers takes a closer look at mRNA and gene editing late-breaking therapies in liver diseases. They discuss the potential of CRISPR Cas9-based technologies in vivo modification of the cellular genome with therapeutic purposes using gene supplementation, correction, or silencing. The review summarises the different gene-editing strategies applied to treating liver diseases, highlighting their therapeutic efficacy and safety concerns.
  • A mini-review by Indian researchers discuss the emerging therapeutic approach using CRISPR-dCas9 to target head and neck cancer epigenetics. The authors suggest that with technological advancements and successful attempts, epigenome editing by CRISPR-dCas9 will have vast therapeutic applications and be widely employed in the near future.
  • The mechanism and delivery of the CRISPR-Cas gene editing system is the subject of a review by researchers in China. The authors mainly focus on nanoparticle-mediated delivery.

Highlights from the American Association for Cancer Research (AACR) 2022 Annual Meeting

Meetings and webinars

Opinions and perspectives

News from CRISPR Medicine News

Huh, Heh, Wow

To get more of the CRISPR Medicine News delivered to your inbox, sign up to the free weekly CMN Newsletter here.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN Weekly

News: CMN Weekly (11 March 2022) - Your Weekly CRISPR Medicine News
Search your next CRISPR job here...
Search your next CRISPR job here...
CLINICAL TRIALS
Solid tumors, (NCT05361174)
Sponsors:
Iovance Biotherapeutics, Inc.
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Sickle Cell Disease, SCD, (NCT05329649)
Sponsors:
Vertex Pharmaceuticals Incorporated
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine